RxDoctor Payments DataLook up a doctor →

Zohra Hussaini

Family · Kansas City, KSNPI 1124326293

Payments from drug & device makers

$328,632in general payments, 2019–2025

Across 865 payments — averaging $379.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Averitas Pharma Inc.$104K
  • GRT US Holding, Inc.$68K
  • Nevro Corp.$51K
  • Vertos Medical, Inc.$36K
  • Painteq LLC$21K
  • SPR Therapeutics, Inc$15K
  • plus $33K from 13 others
$550in research payments, 2019–2025

Across 1 payment — averaging $550.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertos Medical, Inc.$550

What the payments were for

  • Consulting fees$87,22827%
  • Speaking & faculty fees$131,95340%
  • Travel & lodging$80,37124%
  • Food & beverage$28,8009%
  • Education$2800%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$328,632 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$70,082
Medicare patients
309
Services billed
939

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxymorphone Hcl ErOxymorphone Hcl19$11,853
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen426$10,447
OxycontinOxycodone Hcl12$10,016
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen270$9,955
Pregabalin304$9,654
Fentanyl72$9,321
Xtampza ErOxycodone Myristate17$5,929
Gabapentin269$5,275
Oxycodone Hcl242$5,009
Lidocaine27$4,452
Tizanidine Hcl141$2,415
Buprenorphine Hcl69$1,927
Duloxetine Hcl86$1,779
Carbamazepine16$1,666
Morphine Sulfate46$1,394

Paid to pharmacies, not to this prescriber.

Other family in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →